Acadia shares plunge on report FDA is re-examining its drug By: CNBC.com News April 25, 2018 at 14:53 PM EDT Nuplazid, which treats psychosis associated with Parkinson's disease, has been scrutinized for reports of people dying while taking it. Read More >> Related Stocks: Acadia Pharmaceutica